(Go: >> BACK << -|- >> HOME <<)

SlideShare a Scribd company logo
Hepcidin
Dr. Reenaz Shaik
MD Pathology
Anemia
1.6 Billion
people affected
globally with
anemia
Most common:
Iron Deficiency
Anemia
Key Regulator
in Iron
Metabolism:
Hepcidin
 Iron deficiency anemia
 Iron refractory anemia
 Iron overload
 Anemia of Chronic
Disease
 Anemia in kidney
disease
Hepcidin acts as a
Moderator in:
Iron
• A typical human adult has about 3-5 grams of total body iron.
60% of iron is found in circulating haemoglobin
 10% in myoglobin in muscles
20% is stored in liver cells (hepatocytes and Kupffer cells) as ferritin
Rest is divided between enzymes such as cytochromes, peroxidases,
catalase and others.
• To replenish the daily loss of 1-2 mg of iron from mucosal cell sloughing,
sweat and urine excretion, duodenal enterocytes must absorb an equal
amount of iron.
Iron Homeostasis
Duodenal
enterocytes
Absorb iron
Erythroid
precursors
Use Iron
Hepatocytes
and tissue
macrophages
Store Iron
Splenic
macrophages
Recycle Iron
Iron concentrations in our body
are tightly regulated both at
cellular level and systemic level.
Crucial element in maintenance of
Iron homeostasis is effective
communication between
absorption, storage, usage and
recycling of Iron.
Hepcidin
• Hepcidin is a peptide hormone synthesised in hepatocytes. It is
composed of 25 amino acids and includes 4 disulfide bonds which binds
with ferroportin.
• Normal range for plasma hepcidin is in range of 1 to 55 ng/ml.
Decreases Iron Absorption
Increases Iron Absorption
Iron Absorption and Hepcidin
Iron absorption takes place at the
apical surface of duodenal
enterocytes.
Non-haem iron is released from
food as Fe3+ (ferric iron) and
reduced to Fe2+ (ferrous iron) by
duodenal cytochrome b (DCYTB).
Iron is then transported across the
brush-border membrane by the
divalent metal transporter DMT1.
Iron is transported across the
serosal membrane by ferroportin-1.
Potential of Hepcidin as a marker
• Hepcidin can help in diagnosis of Iron deficiency anemia even before routine
haematological parameters and iron profile diagnose anemia.
• Hepcidin helps in differentiating Iron deficiency Anemia and Anemia of Chronic Disease
• Few studies have shown that hepcidin antibodies, BMP agonists or antagonists, cytokine
receptor antibodies can modify hepcidin expression and reverse iron abnormalities in vivo.
• Hepcidin has emerged as the potential marker as it has a known
mechanism of action
good stability
rapid response to iron stores, inflammatory stimuli and bacterial infections
Regulation of Hepcidin
Physiological Induction of Hepcidin: Bone morphogenetic protein
(BMP) along with hemochromatosis protein (HFE), transferrin receptor
2 (TFR2), hemojuvelin (HJV), Metallothionein (MT2) and a specific iron-
related bone morphogenetic protein, BMP6 activates SMAD signalling
pathway. This causes hepcidin transcription.
Pathological hepcidin induction: During inflammation or infection,
interleukin-6 (IL-6) increase hepcidin production. Activation of JAK-
STAT3 pathway by IL6 promotes hepcidin production.
Regulation of Hepcidin
Regulation of Hepcidin
• Physiological hepcidin suppression: When there is an increased demand for
iron during anemia and hypoxia, hepcidin is supressed, independent of the
amount of iron stores present. This is indirectly mediated by the hormone
erythropoietin (EPO) and erythroferrone.
• Pathologic hepcidin suppression: Occurs in the iron-loading anemia. Hepcidin
transcription is suppressed by exuberant but ineffective erythropoiesis.
Hepcidin is also supressed by the cytokines GDF-15 (Growth Differentiating
Factor), TWSG1 (Twisted granulation BMP signalling modulator), Hepatocyte
growth factor (HGF), Epidermal growth factor (EGF).
Correlation of Hepcidin with other anemia markers
Hepcidin Condition Biochemical markers Haematological
markers
Low Iron Deficiency Iron, Ferritin, Tfs
TIBC
Hb , MCV, MCH
RDW
Low Ineffective
erythropoiesis
Iron, Ferritin, Tfs Hb
N RDW
Low Iron Overload Iron, Ferritin, Tfs Hb, MCV, MCH
High Anemia of Chronic
Disease
Iron, Tfs, TIBC
Ferritin
Hb, MCV, MCH
N RDW
Physiological Process in Different Anaemia's:
Type of Anemia Hepcidin
level
Physiological Process
Iron Deficiency Anemia Low Suppression by Erythropoietin
Iron Refractory Anemia High Mutation of TMPRSS6 (Suppressor Matriptase)
Iron Overload Low Suppression due to increased erythropoietic
activities which increases Erythroferrone
Ineffective Erythropoiesis Low Suppression by Cytokines GDF15 and TWSG1
Anemia of Chronic Disease High Induction by Interleukin 6
Anemia in Kidney Disease High Decreased hepcidin clearance and lack of
erythropoietin
Beta Thalassemia (pre-transfusion) Low Suppression by Cytokine GDF15
Beta Thalassemia (post-transfusion) High Due to suppression of erythropoietin
Megaloblastic Anemia Low Decreased nucleotide production causes
ineffective erythropoiesis.
Leukaemia and Lymphoma High Induction by BMP6 and IL6
Hepcidin - Regulation and its role in Iron metabolism

More Related Content

Similar to Hepcidin - Regulation and its role in Iron metabolism

Iron Deficiency Anemia & Recent Advances In Iron Metabolism
Iron Deficiency Anemia &Recent Advances In Iron MetabolismIron Deficiency Anemia &Recent Advances In Iron Metabolism
Iron Deficiency Anemia & Recent Advances In Iron Metabolism
Dr Siddartha
 
Iron Metabolism
Iron MetabolismIron Metabolism
Iron Metabolism
derosaMSKCC
 
Iron Deficiency Anemia
Iron Deficiency AnemiaIron Deficiency Anemia
Iron Deficiency Anemia
Imran Shahzad Anjum
 
Approach to a case of iron defciency anaemia
Approach to a case of iron defciency anaemiaApproach to a case of iron defciency anaemia
Approach to a case of iron defciency anaemia
Sachin Adukia
 
ANAEMIAS CAUSES PREVENTION AND MANAGEMENT.pptx
ANAEMIAS CAUSES PREVENTION AND MANAGEMENT.pptxANAEMIAS CAUSES PREVENTION AND MANAGEMENT.pptx
ANAEMIAS CAUSES PREVENTION AND MANAGEMENT.pptx
AndrewSilungwe2
 
Fluorosis Anemia Iodine deficincey disorder_relation
Fluorosis Anemia Iodine deficincey disorder_relationFluorosis Anemia Iodine deficincey disorder_relation
Fluorosis Anemia Iodine deficincey disorder_relation
drdduttaM
 
Med j club iron overload .
Med j club iron overload .Med j club iron overload .
Med j club iron overload .
Shaikhani.
 
Haematinics
HaematinicsHaematinics
Haematinics
lavenyaramamoorthi
 
iron deficiency anemia
iron deficiency anemia iron deficiency anemia
iron deficiency anemia
Aayush Rai
 
2 microcytic anemia i-iron deficiency.ppt
2 microcytic anemia i-iron deficiency.ppt2 microcytic anemia i-iron deficiency.ppt
2 microcytic anemia i-iron deficiency.ppt
AbdulKaderSouid
 
Iron overload
Iron overloadIron overload
Iron overload
Niveen Daoud
 
Iron refractory iron deficiency anemia1
Iron refractory iron deficiency anemia1Iron refractory iron deficiency anemia1
Iron refractory iron deficiency anemia1
MervatAtfy
 
Iron Metabolism
Iron MetabolismIron Metabolism
Iron Metabolism
Azza Elkady
 
Hematopoietic Drugs
Hematopoietic DrugsHematopoietic Drugs
Hematopoietic Drugs
Eneutron
 
Hepcidin
HepcidinHepcidin
Hepcidin
santosari
 
Iron Refractory Iron Deficiency Anemia.pptx
Iron Refractory Iron Deficiency Anemia.pptxIron Refractory Iron Deficiency Anemia.pptx
Iron Refractory Iron Deficiency Anemia.pptx
biswajitbhuyan14
 
Hematinic I
Hematinic IHematinic I
Hematinic I
nukieaditia
 
Hematinic I
Hematinic IHematinic I
Hematinic I
nukieaditia
 
Hematinic I ARF: Iron
Hematinic I ARF: IronHematinic I ARF: Iron
Hematinic I ARF: Iron
AditiaFitri
 
IRON DEFICIENCY ANEMIA .pptx
IRON DEFICIENCY ANEMIA .pptxIRON DEFICIENCY ANEMIA .pptx
IRON DEFICIENCY ANEMIA .pptx
Santurims
 

Similar to Hepcidin - Regulation and its role in Iron metabolism (20)

Iron Deficiency Anemia & Recent Advances In Iron Metabolism
Iron Deficiency Anemia &Recent Advances In Iron MetabolismIron Deficiency Anemia &Recent Advances In Iron Metabolism
Iron Deficiency Anemia & Recent Advances In Iron Metabolism
 
Iron Metabolism
Iron MetabolismIron Metabolism
Iron Metabolism
 
Iron Deficiency Anemia
Iron Deficiency AnemiaIron Deficiency Anemia
Iron Deficiency Anemia
 
Approach to a case of iron defciency anaemia
Approach to a case of iron defciency anaemiaApproach to a case of iron defciency anaemia
Approach to a case of iron defciency anaemia
 
ANAEMIAS CAUSES PREVENTION AND MANAGEMENT.pptx
ANAEMIAS CAUSES PREVENTION AND MANAGEMENT.pptxANAEMIAS CAUSES PREVENTION AND MANAGEMENT.pptx
ANAEMIAS CAUSES PREVENTION AND MANAGEMENT.pptx
 
Fluorosis Anemia Iodine deficincey disorder_relation
Fluorosis Anemia Iodine deficincey disorder_relationFluorosis Anemia Iodine deficincey disorder_relation
Fluorosis Anemia Iodine deficincey disorder_relation
 
Med j club iron overload .
Med j club iron overload .Med j club iron overload .
Med j club iron overload .
 
Haematinics
HaematinicsHaematinics
Haematinics
 
iron deficiency anemia
iron deficiency anemia iron deficiency anemia
iron deficiency anemia
 
2 microcytic anemia i-iron deficiency.ppt
2 microcytic anemia i-iron deficiency.ppt2 microcytic anemia i-iron deficiency.ppt
2 microcytic anemia i-iron deficiency.ppt
 
Iron overload
Iron overloadIron overload
Iron overload
 
Iron refractory iron deficiency anemia1
Iron refractory iron deficiency anemia1Iron refractory iron deficiency anemia1
Iron refractory iron deficiency anemia1
 
Iron Metabolism
Iron MetabolismIron Metabolism
Iron Metabolism
 
Hematopoietic Drugs
Hematopoietic DrugsHematopoietic Drugs
Hematopoietic Drugs
 
Hepcidin
HepcidinHepcidin
Hepcidin
 
Iron Refractory Iron Deficiency Anemia.pptx
Iron Refractory Iron Deficiency Anemia.pptxIron Refractory Iron Deficiency Anemia.pptx
Iron Refractory Iron Deficiency Anemia.pptx
 
Hematinic I
Hematinic IHematinic I
Hematinic I
 
Hematinic I
Hematinic IHematinic I
Hematinic I
 
Hematinic I ARF: Iron
Hematinic I ARF: IronHematinic I ARF: Iron
Hematinic I ARF: Iron
 
IRON DEFICIENCY ANEMIA .pptx
IRON DEFICIENCY ANEMIA .pptxIRON DEFICIENCY ANEMIA .pptx
IRON DEFICIENCY ANEMIA .pptx
 

More from Reenaz Shaik

Acute Tubular Necrosis - Ischemic and Toxic ATN
Acute Tubular Necrosis - Ischemic and Toxic ATNAcute Tubular Necrosis - Ischemic and Toxic ATN
Acute Tubular Necrosis - Ischemic and Toxic ATN
Reenaz Shaik
 
RENAL FAILURE - Clinical Syndromes, Acute and Chronic Renal Failure
RENAL FAILURE - Clinical Syndromes, Acute and Chronic Renal FailureRENAL FAILURE - Clinical Syndromes, Acute and Chronic Renal Failure
RENAL FAILURE - Clinical Syndromes, Acute and Chronic Renal Failure
Reenaz Shaik
 
Lung Abscess and Pneumonia (Pathology)
Lung Abscess and Pneumonia   (Pathology)Lung Abscess and Pneumonia   (Pathology)
Lung Abscess and Pneumonia (Pathology)
Reenaz Shaik
 
WOUND HEALING - Stages, Types, Complications.
WOUND HEALING - Stages, Types, Complications.WOUND HEALING - Stages, Types, Complications.
WOUND HEALING - Stages, Types, Complications.
Reenaz Shaik
 
Tumor Immunology and role of antigens in analysis of anaplastic tumors.
Tumor Immunology and role of antigens in analysis of anaplastic tumors.Tumor Immunology and role of antigens in analysis of anaplastic tumors.
Tumor Immunology and role of antigens in analysis of anaplastic tumors.
Reenaz Shaik
 
Westgard's rules and LJ (Levey Jennings) Charts.
Westgard's rules and LJ (Levey Jennings) Charts.Westgard's rules and LJ (Levey Jennings) Charts.
Westgard's rules and LJ (Levey Jennings) Charts.
Reenaz Shaik
 
Perivascular Epithelioid Cell Tumors ( PEComa) of GIT
Perivascular Epithelioid Cell Tumors ( PEComa) of GITPerivascular Epithelioid Cell Tumors ( PEComa) of GIT
Perivascular Epithelioid Cell Tumors ( PEComa) of GIT
Reenaz Shaik
 
Myeloproliferative Disorders ( MPD )
Myeloproliferative Disorders     ( MPD )Myeloproliferative Disorders     ( MPD )
Myeloproliferative Disorders ( MPD )
Reenaz Shaik
 
Minimal Residual Disease (MRD)
Minimal Residual Disease           (MRD)Minimal Residual Disease           (MRD)
Minimal Residual Disease (MRD)
Reenaz Shaik
 
Juvenile Myelomonocytic Leukemia (JMML)
Juvenile Myelomonocytic Leukemia   (JMML)Juvenile Myelomonocytic Leukemia   (JMML)
Juvenile Myelomonocytic Leukemia (JMML)
Reenaz Shaik
 
Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytic Lymphohistiocytosis (HLH)Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytic Lymphohistiocytosis (HLH)
Reenaz Shaik
 
Immature platelet fraction (IPF)(Reticulated Platelets)
Immature platelet fraction (IPF)(Reticulated Platelets)Immature platelet fraction (IPF)(Reticulated Platelets)
Immature platelet fraction (IPF)(Reticulated Platelets)
Reenaz Shaik
 
Familial Histiocytic Proliferative Lesions
Familial Histiocytic Proliferative LesionsFamilial Histiocytic Proliferative Lesions
Familial Histiocytic Proliferative Lesions
Reenaz Shaik
 
Hb electrophoresis- Types, Procedure and Analysis
Hb electrophoresis- Types, Procedure and AnalysisHb electrophoresis- Types, Procedure and Analysis
Hb electrophoresis- Types, Procedure and Analysis
Reenaz Shaik
 
Gene therapy - Types, Advantages and genetic manifestations in molecular med...
Gene therapy - Types, Advantages and  genetic manifestations in molecular med...Gene therapy - Types, Advantages and  genetic manifestations in molecular med...
Gene therapy - Types, Advantages and genetic manifestations in molecular med...
Reenaz Shaik
 
Male Infertility and Investigations
Male Infertility and InvestigationsMale Infertility and Investigations
Male Infertility and Investigations
Reenaz Shaik
 
Embyonal Stem Cells - Properties and Classification
Embyonal Stem Cells - Properties and ClassificationEmbyonal Stem Cells - Properties and Classification
Embyonal Stem Cells - Properties and Classification
Reenaz Shaik
 

More from Reenaz Shaik (17)

Acute Tubular Necrosis - Ischemic and Toxic ATN
Acute Tubular Necrosis - Ischemic and Toxic ATNAcute Tubular Necrosis - Ischemic and Toxic ATN
Acute Tubular Necrosis - Ischemic and Toxic ATN
 
RENAL FAILURE - Clinical Syndromes, Acute and Chronic Renal Failure
RENAL FAILURE - Clinical Syndromes, Acute and Chronic Renal FailureRENAL FAILURE - Clinical Syndromes, Acute and Chronic Renal Failure
RENAL FAILURE - Clinical Syndromes, Acute and Chronic Renal Failure
 
Lung Abscess and Pneumonia (Pathology)
Lung Abscess and Pneumonia   (Pathology)Lung Abscess and Pneumonia   (Pathology)
Lung Abscess and Pneumonia (Pathology)
 
WOUND HEALING - Stages, Types, Complications.
WOUND HEALING - Stages, Types, Complications.WOUND HEALING - Stages, Types, Complications.
WOUND HEALING - Stages, Types, Complications.
 
Tumor Immunology and role of antigens in analysis of anaplastic tumors.
Tumor Immunology and role of antigens in analysis of anaplastic tumors.Tumor Immunology and role of antigens in analysis of anaplastic tumors.
Tumor Immunology and role of antigens in analysis of anaplastic tumors.
 
Westgard's rules and LJ (Levey Jennings) Charts.
Westgard's rules and LJ (Levey Jennings) Charts.Westgard's rules and LJ (Levey Jennings) Charts.
Westgard's rules and LJ (Levey Jennings) Charts.
 
Perivascular Epithelioid Cell Tumors ( PEComa) of GIT
Perivascular Epithelioid Cell Tumors ( PEComa) of GITPerivascular Epithelioid Cell Tumors ( PEComa) of GIT
Perivascular Epithelioid Cell Tumors ( PEComa) of GIT
 
Myeloproliferative Disorders ( MPD )
Myeloproliferative Disorders     ( MPD )Myeloproliferative Disorders     ( MPD )
Myeloproliferative Disorders ( MPD )
 
Minimal Residual Disease (MRD)
Minimal Residual Disease           (MRD)Minimal Residual Disease           (MRD)
Minimal Residual Disease (MRD)
 
Juvenile Myelomonocytic Leukemia (JMML)
Juvenile Myelomonocytic Leukemia   (JMML)Juvenile Myelomonocytic Leukemia   (JMML)
Juvenile Myelomonocytic Leukemia (JMML)
 
Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytic Lymphohistiocytosis (HLH)Hemophagocytic Lymphohistiocytosis (HLH)
Hemophagocytic Lymphohistiocytosis (HLH)
 
Immature platelet fraction (IPF)(Reticulated Platelets)
Immature platelet fraction (IPF)(Reticulated Platelets)Immature platelet fraction (IPF)(Reticulated Platelets)
Immature platelet fraction (IPF)(Reticulated Platelets)
 
Familial Histiocytic Proliferative Lesions
Familial Histiocytic Proliferative LesionsFamilial Histiocytic Proliferative Lesions
Familial Histiocytic Proliferative Lesions
 
Hb electrophoresis- Types, Procedure and Analysis
Hb electrophoresis- Types, Procedure and AnalysisHb electrophoresis- Types, Procedure and Analysis
Hb electrophoresis- Types, Procedure and Analysis
 
Gene therapy - Types, Advantages and genetic manifestations in molecular med...
Gene therapy - Types, Advantages and  genetic manifestations in molecular med...Gene therapy - Types, Advantages and  genetic manifestations in molecular med...
Gene therapy - Types, Advantages and genetic manifestations in molecular med...
 
Male Infertility and Investigations
Male Infertility and InvestigationsMale Infertility and Investigations
Male Infertility and Investigations
 
Embyonal Stem Cells - Properties and Classification
Embyonal Stem Cells - Properties and ClassificationEmbyonal Stem Cells - Properties and Classification
Embyonal Stem Cells - Properties and Classification
 

Recently uploaded

Accommodation and Convergence measurement and types
Accommodation and Convergence measurement and types Accommodation and Convergence measurement and types
Accommodation and Convergence measurement and types
PriyanshSharma67
 
Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...
Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...
Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...
PVI, PeerView Institute for Medical Education
 
SHOCK management and types and ways of diagnosis
SHOCK management and types and ways of diagnosisSHOCK management and types and ways of diagnosis
SHOCK management and types and ways of diagnosis
Lway1
 
Metabolic interrelationship MBBS II.pptx
Metabolic interrelationship MBBS II.pptxMetabolic interrelationship MBBS II.pptx
Metabolic interrelationship MBBS II.pptx
apeksha40
 
Coronary Circulation and Ischemic Heart Disease_AntiCopy.pdf
Coronary Circulation and Ischemic Heart Disease_AntiCopy.pdfCoronary Circulation and Ischemic Heart Disease_AntiCopy.pdf
Coronary Circulation and Ischemic Heart Disease_AntiCopy.pdf
MedicoseAcademics
 
Introduction to Removable partial dneture.pptx
Introduction to Removable partial dneture.pptxIntroduction to Removable partial dneture.pptx
Introduction to Removable partial dneture.pptx
Shamsuddin Mahmud
 
Nursing management of patient with peritoneal dialysis
Nursing management of patient with peritoneal dialysisNursing management of patient with peritoneal dialysis
Nursing management of patient with peritoneal dialysis
shivalingatalekar1
 
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
PVI, PeerView Institute for Medical Education
 
EligibilityDesignAssistant_demo_slideshare.pptx.pdf
EligibilityDesignAssistant_demo_slideshare.pptx.pdfEligibilityDesignAssistant_demo_slideshare.pptx.pdf
EligibilityDesignAssistant_demo_slideshare.pptx.pdf
Ontotext
 
How to build a successful medical tourism practice
How to build a successful medical tourism practiceHow to build a successful medical tourism practice
How to build a successful medical tourism practice
Arlen Meyers, MD, MBA
 
Larry Smarr’s Prostate Cancer Early Detection and Focal Therapy
Larry Smarr’s Prostate Cancer Early Detection and Focal TherapyLarry Smarr’s Prostate Cancer Early Detection and Focal Therapy
Larry Smarr’s Prostate Cancer Early Detection and Focal Therapy
Larry Smarr
 
Hepatocarcinoma today between guidelines and medical therapy. The role of sur...
Hepatocarcinoma today between guidelines and medical therapy. The role of sur...Hepatocarcinoma today between guidelines and medical therapy. The role of sur...
Hepatocarcinoma today between guidelines and medical therapy. The role of sur...
Gian Luca Grazi
 
A comparative study on uroculturome antimicrobial susceptibility in apparentl...
A comparative study on uroculturome antimicrobial susceptibility in apparentl...A comparative study on uroculturome antimicrobial susceptibility in apparentl...
A comparative study on uroculturome antimicrobial susceptibility in apparentl...
Bhoj Raj Singh
 
Prodrug design for Sustained Drug action -.KB.pptx
Prodrug design for Sustained Drug action -.KB.pptxProdrug design for Sustained Drug action -.KB.pptx
Prodrug design for Sustained Drug action -.KB.pptx
ANAGHA K B
 
Giant Breast Lipoma Masquerading as Breast Enlargement ورم شحمي عملاق للثدي م...
Giant Breast Lipoma Masquerading as Breast Enlargement ورم شحمي عملاق للثدي م...Giant Breast Lipoma Masquerading as Breast Enlargement ورم شحمي عملاق للثدي م...
Giant Breast Lipoma Masquerading as Breast Enlargement ورم شحمي عملاق للثدي م...
Mohamad محمد Al-Gailani الكيلاني
 
Why Does Seminal Vesiculitis Causes Jelly-like Sperm.pptx
Why Does Seminal Vesiculitis Causes Jelly-like Sperm.pptxWhy Does Seminal Vesiculitis Causes Jelly-like Sperm.pptx
Why Does Seminal Vesiculitis Causes Jelly-like Sperm.pptx
AmandaChou9
 
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.Gawad
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.GawadHemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.Gawad
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.Gawad
NephroTube - Dr.Gawad
 
Nursing Lecture 428 slide presentation. PDF
Nursing Lecture 428 slide presentation. PDFNursing Lecture 428 slide presentation. PDF
Nursing Lecture 428 slide presentation. PDF
MuhammadMunirAbdulka1
 
Abnormal CSF Diagnosis and Lumbar puncture
Abnormal CSF Diagnosis and Lumbar punctureAbnormal CSF Diagnosis and Lumbar puncture
Abnormal CSF Diagnosis and Lumbar puncture
Preet Mehta
 
Coronary Bifurcation techniques in a nutshell
Coronary Bifurcation techniques in a nutshellCoronary Bifurcation techniques in a nutshell
Coronary Bifurcation techniques in a nutshell
AhmedElBorae1
 

Recently uploaded (20)

Accommodation and Convergence measurement and types
Accommodation and Convergence measurement and types Accommodation and Convergence measurement and types
Accommodation and Convergence measurement and types
 
Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...
Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...
Mastering Diagnosis and Navigating the Sea of Targeted Treatments in NMOSD: P...
 
SHOCK management and types and ways of diagnosis
SHOCK management and types and ways of diagnosisSHOCK management and types and ways of diagnosis
SHOCK management and types and ways of diagnosis
 
Metabolic interrelationship MBBS II.pptx
Metabolic interrelationship MBBS II.pptxMetabolic interrelationship MBBS II.pptx
Metabolic interrelationship MBBS II.pptx
 
Coronary Circulation and Ischemic Heart Disease_AntiCopy.pdf
Coronary Circulation and Ischemic Heart Disease_AntiCopy.pdfCoronary Circulation and Ischemic Heart Disease_AntiCopy.pdf
Coronary Circulation and Ischemic Heart Disease_AntiCopy.pdf
 
Introduction to Removable partial dneture.pptx
Introduction to Removable partial dneture.pptxIntroduction to Removable partial dneture.pptx
Introduction to Removable partial dneture.pptx
 
Nursing management of patient with peritoneal dialysis
Nursing management of patient with peritoneal dialysisNursing management of patient with peritoneal dialysis
Nursing management of patient with peritoneal dialysis
 
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
Decoding Biomarker Testing and Targeted Therapy in NSCLC: The Complete Guide ...
 
EligibilityDesignAssistant_demo_slideshare.pptx.pdf
EligibilityDesignAssistant_demo_slideshare.pptx.pdfEligibilityDesignAssistant_demo_slideshare.pptx.pdf
EligibilityDesignAssistant_demo_slideshare.pptx.pdf
 
How to build a successful medical tourism practice
How to build a successful medical tourism practiceHow to build a successful medical tourism practice
How to build a successful medical tourism practice
 
Larry Smarr’s Prostate Cancer Early Detection and Focal Therapy
Larry Smarr’s Prostate Cancer Early Detection and Focal TherapyLarry Smarr’s Prostate Cancer Early Detection and Focal Therapy
Larry Smarr’s Prostate Cancer Early Detection and Focal Therapy
 
Hepatocarcinoma today between guidelines and medical therapy. The role of sur...
Hepatocarcinoma today between guidelines and medical therapy. The role of sur...Hepatocarcinoma today between guidelines and medical therapy. The role of sur...
Hepatocarcinoma today between guidelines and medical therapy. The role of sur...
 
A comparative study on uroculturome antimicrobial susceptibility in apparentl...
A comparative study on uroculturome antimicrobial susceptibility in apparentl...A comparative study on uroculturome antimicrobial susceptibility in apparentl...
A comparative study on uroculturome antimicrobial susceptibility in apparentl...
 
Prodrug design for Sustained Drug action -.KB.pptx
Prodrug design for Sustained Drug action -.KB.pptxProdrug design for Sustained Drug action -.KB.pptx
Prodrug design for Sustained Drug action -.KB.pptx
 
Giant Breast Lipoma Masquerading as Breast Enlargement ورم شحمي عملاق للثدي م...
Giant Breast Lipoma Masquerading as Breast Enlargement ورم شحمي عملاق للثدي م...Giant Breast Lipoma Masquerading as Breast Enlargement ورم شحمي عملاق للثدي م...
Giant Breast Lipoma Masquerading as Breast Enlargement ورم شحمي عملاق للثدي م...
 
Why Does Seminal Vesiculitis Causes Jelly-like Sperm.pptx
Why Does Seminal Vesiculitis Causes Jelly-like Sperm.pptxWhy Does Seminal Vesiculitis Causes Jelly-like Sperm.pptx
Why Does Seminal Vesiculitis Causes Jelly-like Sperm.pptx
 
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.Gawad
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.GawadHemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.Gawad
Hemodialysis: Chapter 8, Complications During Hemodialysis, Part 2 - Dr.Gawad
 
Nursing Lecture 428 slide presentation. PDF
Nursing Lecture 428 slide presentation. PDFNursing Lecture 428 slide presentation. PDF
Nursing Lecture 428 slide presentation. PDF
 
Abnormal CSF Diagnosis and Lumbar puncture
Abnormal CSF Diagnosis and Lumbar punctureAbnormal CSF Diagnosis and Lumbar puncture
Abnormal CSF Diagnosis and Lumbar puncture
 
Coronary Bifurcation techniques in a nutshell
Coronary Bifurcation techniques in a nutshellCoronary Bifurcation techniques in a nutshell
Coronary Bifurcation techniques in a nutshell
 

Hepcidin - Regulation and its role in Iron metabolism

  • 2. Anemia 1.6 Billion people affected globally with anemia Most common: Iron Deficiency Anemia Key Regulator in Iron Metabolism: Hepcidin  Iron deficiency anemia  Iron refractory anemia  Iron overload  Anemia of Chronic Disease  Anemia in kidney disease Hepcidin acts as a Moderator in:
  • 3. Iron • A typical human adult has about 3-5 grams of total body iron. 60% of iron is found in circulating haemoglobin  10% in myoglobin in muscles 20% is stored in liver cells (hepatocytes and Kupffer cells) as ferritin Rest is divided between enzymes such as cytochromes, peroxidases, catalase and others. • To replenish the daily loss of 1-2 mg of iron from mucosal cell sloughing, sweat and urine excretion, duodenal enterocytes must absorb an equal amount of iron.
  • 4. Iron Homeostasis Duodenal enterocytes Absorb iron Erythroid precursors Use Iron Hepatocytes and tissue macrophages Store Iron Splenic macrophages Recycle Iron Iron concentrations in our body are tightly regulated both at cellular level and systemic level. Crucial element in maintenance of Iron homeostasis is effective communication between absorption, storage, usage and recycling of Iron.
  • 5. Hepcidin • Hepcidin is a peptide hormone synthesised in hepatocytes. It is composed of 25 amino acids and includes 4 disulfide bonds which binds with ferroportin. • Normal range for plasma hepcidin is in range of 1 to 55 ng/ml. Decreases Iron Absorption Increases Iron Absorption
  • 6. Iron Absorption and Hepcidin Iron absorption takes place at the apical surface of duodenal enterocytes. Non-haem iron is released from food as Fe3+ (ferric iron) and reduced to Fe2+ (ferrous iron) by duodenal cytochrome b (DCYTB). Iron is then transported across the brush-border membrane by the divalent metal transporter DMT1. Iron is transported across the serosal membrane by ferroportin-1.
  • 7. Potential of Hepcidin as a marker • Hepcidin can help in diagnosis of Iron deficiency anemia even before routine haematological parameters and iron profile diagnose anemia. • Hepcidin helps in differentiating Iron deficiency Anemia and Anemia of Chronic Disease • Few studies have shown that hepcidin antibodies, BMP agonists or antagonists, cytokine receptor antibodies can modify hepcidin expression and reverse iron abnormalities in vivo. • Hepcidin has emerged as the potential marker as it has a known mechanism of action good stability rapid response to iron stores, inflammatory stimuli and bacterial infections
  • 8. Regulation of Hepcidin Physiological Induction of Hepcidin: Bone morphogenetic protein (BMP) along with hemochromatosis protein (HFE), transferrin receptor 2 (TFR2), hemojuvelin (HJV), Metallothionein (MT2) and a specific iron- related bone morphogenetic protein, BMP6 activates SMAD signalling pathway. This causes hepcidin transcription. Pathological hepcidin induction: During inflammation or infection, interleukin-6 (IL-6) increase hepcidin production. Activation of JAK- STAT3 pathway by IL6 promotes hepcidin production.
  • 10. Regulation of Hepcidin • Physiological hepcidin suppression: When there is an increased demand for iron during anemia and hypoxia, hepcidin is supressed, independent of the amount of iron stores present. This is indirectly mediated by the hormone erythropoietin (EPO) and erythroferrone. • Pathologic hepcidin suppression: Occurs in the iron-loading anemia. Hepcidin transcription is suppressed by exuberant but ineffective erythropoiesis. Hepcidin is also supressed by the cytokines GDF-15 (Growth Differentiating Factor), TWSG1 (Twisted granulation BMP signalling modulator), Hepatocyte growth factor (HGF), Epidermal growth factor (EGF).
  • 11. Correlation of Hepcidin with other anemia markers Hepcidin Condition Biochemical markers Haematological markers Low Iron Deficiency Iron, Ferritin, Tfs TIBC Hb , MCV, MCH RDW Low Ineffective erythropoiesis Iron, Ferritin, Tfs Hb N RDW Low Iron Overload Iron, Ferritin, Tfs Hb, MCV, MCH High Anemia of Chronic Disease Iron, Tfs, TIBC Ferritin Hb, MCV, MCH N RDW
  • 12. Physiological Process in Different Anaemia's: Type of Anemia Hepcidin level Physiological Process Iron Deficiency Anemia Low Suppression by Erythropoietin Iron Refractory Anemia High Mutation of TMPRSS6 (Suppressor Matriptase) Iron Overload Low Suppression due to increased erythropoietic activities which increases Erythroferrone Ineffective Erythropoiesis Low Suppression by Cytokines GDF15 and TWSG1 Anemia of Chronic Disease High Induction by Interleukin 6 Anemia in Kidney Disease High Decreased hepcidin clearance and lack of erythropoietin Beta Thalassemia (pre-transfusion) Low Suppression by Cytokine GDF15 Beta Thalassemia (post-transfusion) High Due to suppression of erythropoietin Megaloblastic Anemia Low Decreased nucleotide production causes ineffective erythropoiesis. Leukaemia and Lymphoma High Induction by BMP6 and IL6